click
Contact

Tag: AOCs

AOC Development: Conjugation Site Selection, DAR Control & In Vitro Testing | Full Webinar

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

Oligonucleotide therapeutics hold great promise, but extrahepatic delivery remains a challenge. Antibody–oligonucleotide conjugates (AOCs) are emerging as a powerful solution – provided you can master conjugation chemistry, DAR control, analytical characterization, and functional assessment. https://www.youtube.com/watch?v=CNr9ZsU2qrk In this recorded webinar, our experts from Medicilon cover: How conjugation chemistry impacts AOC consistency and developability Why DAR control […]

BioTrinity 2026

Medicilon Events

April 14-15, 2026
Convene, 133 Houndsditch, London EC3A 7BX, United Kingdom

Contact

Search Medicilon

Preclinical CRO

Medicilon Webinar | IND-enabling Toxicity Studies, CTD Documentation and Translational Cardiac Risk Assessment

Read more
Preclinical CRO

Medicilon Stands Out at ASMS 2026: Only CRO Selected for Bioanalysis Zone’s ‘Pick of the Posters’

Read more
Preclinical CRO

Medicilon Congratulates Livzon Pharmaceutical on the Approval of LiYouBao® — China’s Only Export-Qualified r-FSH Injection Meeting Global International Standards

Read more

Contact Medicilon

Name(Required)
Address(Required)